← Back to patent-cliff list
CAS 243636-56-8
2-amino-7-(1-phenylethyl)-5-vinyl-3,5,6,7-tetrahydro-4H-pyrrolo[2,3-d]pyrimidin-4-one
Codes: PEME-037
Application context (from source-drug indications)
Non-small cell lung cancerPemetrexed Disodium Hydrate间皮组织肿瘤Pemetrexed Disodium Hydrate胸膜孤立性纤维瘤Pemetrexed Disodium HydrateBladder cancerPemetrexed Disodium HydrateUrothelial carcinomaPemetrexed Disodium HydrateSolid tumourPemetrexed Disodium Hydrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Pemetrexed Disodium Hydrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
guanidine→1-phenylethan-1-amine→methyl carbonochloridate→methyl (1-phenylethyl)carbamate→(E)-1-bromobut-2-ene→methyl (E)-but-2-en-1-yl(1-phenylethyl)carbamate→(E)-N-(1-phenylethyl)but-2-en-1-amine→dimethyl malonate→methyl (E)-3-(but-2-en-1-yl(1-phenylethyl)amino)-3-oxopropanoate→methyl 2-oxo-1-(1-phenylethyl)-4-vinylpyrrolidine-3-carboxylate→methyl 1-(1-phenylethyl)-2-thioxo-4-vinylpyrrolidine-3-carboxylate→2-amino-7-(1-phenylethyl)-5-vinyl-3,5,6,7-tetrahydro-4H-pyrrolo[2,3-d]pyrimidin-4-one→diethyl (4-iodobenzoyl)-L-glutamate→diethyl (4-(2-(2-amino-4-oxo-7-(1-phenylethyl)-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzoyl)-L-glutamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.